The US FDA has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes.

Earlier this month, non-profit drugmaker Civica Rx pledged to launch biosimilars of three big-selling insulin products in the US – Sanofi's Lantus, Novo Nordisk's Novolog and Eli Lilly's Humalog ...

It sells products through independent distributors ... its first indigenously manufactured re-usable insulin pen.On 14 February 2013, Sanofi India Limited announced the launch of Combiflam Plus ...

The non-profit drugmaker plans to launch biosimilars of Sanofi’s Lantus (insulin glargine ... of drastically reducing the price of the insulin products, compared to the branded products ...

Insulin pump therapy ... to consider the interactions of users with the technical features of their products is limited. The clinical studies required by regulators prior to marketing are small ...

Containing fake, counterfeit drugs still a long way to go HEART-RENDING as these accounts by relatives of victims appear, ...

Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...

This growth comes on the back of a steady market performance from 2017 to 2022, where the injection pen sector achieved a ...

California dedicated $100 to manufacturing insulin for diabetic residents. That effort is taking longer than Gov. Gavin ...

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...